IFRX – inflarx n.v. (US:NASDAQ)
Stock Stats
News
3/31
07:30 am
ifrx
Medium
InflaRx Announces Participation in the Raymond James 2026 Biotech Innovation Symposium
3/30
07:30 am
ifrx
Medium
InflaRx Highlights Clinical Activity of Vilobelimab in Pyoderma Gangrenosum in Late-Breaker Oral Presentation at 2026 American Academy of Dermatology Annual Meeting
3/20
08:44 am
ifrx
Medium
InflaRx (IFRX) had its price target lowered by Guggenheim from $22.00 to $14.00. They now have a "buy" rating on the stock.
3/19
07:30 am
ifrx
Medium
InflaRx Reports Full Year 2025 Results and Highlights Key Achievements and Expected Milestones
3/18
07:30 am
ifrx
Medium
InflaRx Announces Late-Breaker Oral Presentation on Vilobelimab Phase 3 Results in Pyoderma Gangrenosum at 2026 American Academy of Dermatology Annual Meeting
3/19/2026
07:30 am
IFRX
4.6%
MISS
8/7/2025
07:30 am
IFRX
-1.6%
BEAT
5/7/2025
07:30 am
IFRX
-8.0%
BEAT
3/20
08:40 am
Maintains
Buy
Buy
Guggenheim
Medium
3.3%
3/20
08:40 am
Maintains
Buy
Buy
Guggenheim
Medium
3.3%
4/2
04:19 pm
ifrx
Neutral
Form 6-K InflaRx N.V. For: Apr 02
3/20
07:37 am
ifrx
Medium
Form 20-F InflaRx N.V. For: Dec 31
3/19
07:45 am
ifrx
Medium
Form 6-K InflaRx N.V. For: Mar 19
3/18
08:17 am
ifrx
High
Form 3 InflaRx N.V. For: Mar 18 Filed by: Kubler Mark
3/18
08:16 am
ifrx
High
Form 3 InflaRx N.V. For: Mar 18 Filed by: Gibney Anthony S
Show more
Top News Gainers
3/31 InflaRx Doses First Patient in Multicenter Randomized Clinical Trial in Severe Progressed COVID-19 Pneumonia in Europe upon Receipt of Initial Positive Human Data with InflaRx’s anti-C5a Technology 50.0%
4/29 Form 20-F InflaRx N.V. For: Dec 31 30.0%
2/14 Form SC 13G/A InflaRx N.V. Filed by: Cormorant Asset Management, LP 23.6%
2/19 InflaRx to Present at Upcoming SVB Leerink Global Healthcare Conference 14.9%
2/26 Form 6-K InflaRx N.V. For: Feb 26 14.1%
6/12 Inflarx NV (NASDAQ: IFRX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $3.75 price target on the stock. 6.1%
1/8 Inflarx NV (NASDAQ: IFRX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.00 price target on the stock. 5.2%
10/23 Inflarx NV (NASDAQ: IFRX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 4.9%
6/14 Form 6-K InflaRx N.V. For: Jun 14 4.7%
6/13 InflaRx Treats First Patient in Phase IIa Clinical Trial with Lead Candidate IFX-1 in Pyoderma Gangraenosum 3.6%
Top News Decliners
6/5 Form 6-K InflaRx N.V. For: Jun 05 -91.8%
4/1 Form 6-K InflaRx N.V. For: Mar 31 -34.4%
3/2 Form 6-K InflaRx N.V. For: Mar 02 -23.5%
11/7 Form 6-K InflaRx N.V. For: Nov 07 -21.7%
7/18 Form 6-K InflaRx N.V. For: Jul 18 -16.0%
5/23 Form 6-K InflaRx N.V. For: May 23 -10.2%
4/29 InflaRx Reports Full Year 2019 Financial & Operating Results -7.8%
11/14 Form 6-K InflaRx N.V. For: Nov 14 -5.3%
4/9 Form 6-K InflaRx N.V. For: Apr 09 -3.1%
2/26 InflaRx Announces Positive Initial Data from Ongoing Phase IIa Open Label Study with IFX-1 in Patients Suffering from Pyoderma Gangraenosum -3.0%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3